ERBB3 and neoplasm: Similar to lapatinib-stimulation of HER2 levels only in castrated mice bearing 22Rv1 tumours (Fig. 1d), we saw increased EGFR/HER2 (but not EGFR/ErbB3) heterodimerisation with lapatinib only in CRPC cells in CSS (Fig. 3d).